Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
Psychotropic Medication Use and Ectopic Pregnancy
FY 2018-19
Summary
In up to 2% of pregnancies, the embryo implants and begins to develop outside of the uterus - this is referred to as an ectopic pregnancy (EP). These pregnancies are extremely painful, can result in serious complications, and are responsible up to 13% of all pregnancy-related deaths. EPs occur when the fallopian tube environment changes, preventing the embryo from moving to the uterus. Since the embryo moves through the fallopian tube by muscle contraction and ciliary beating, exposures that affect either of these mechanisms could potentially result in EP.
This study is the first to look at whether the risk of EP is higher for women who use SSRIs, a common type of antidepressant that can affect ciliary beating in the fallopian tube, or benzodiazepines, a common type of anti-anxiety drug that can affect muscle contractions in the fallopian tube. The rate of SSRI and benzodiazepine prescriptions are rising, but virtually nothing is known about the impact of these medications on early pregnancy outcomes such as EP. This study will use large administrative claims databases of over 2 million pregnancies and advanced methods to make considerable strides toward understanding, and potentially reducing the incidence of, EP.
The findings from this research are important contributions to the fields of perinatal epidemiology and pharmacoepidemiology. Since EPs never progress past the first trimester, they are largely neglected in both fields. Given the serious outcomes associated with EPs (complications and death), this topic deserves a lot more attention. The rate of EP is high in Canada, ranging from less than 1% of reported pregnancies in Prince Edward Island, to more than 3% of reported pregnancies in the Northwest Territories. The findings from this research can contribute towards guidelines for the prescription of SSRIs and benzodiazepines for women of reproductive age in Canada.
Department
Program
Banting Postdoctoral Fellowship Program
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
392226
Name
Wall-Wieler Elizabeth
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Psychotropic Medication Use and Ectopic Pregnancy
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Administrative Claims Data; Ectopic Pregnancy; Epidemiology; Psychotropic Medication
Abstract
In up to 2% of pregnancies, the embryo implants and begins to develop outside of the uterus - this is referred to as an ectopic pregnancy (EP). These pregnancies are extremely painful, can result in serious complications, and are responsible up to 13% of all pregnancy-related deaths. EPs occur when the fallopian tube environment changes, preventing the embryo from moving to the uterus. Since the embryo moves through the fallopian tube by muscle contraction and ciliary beating, exposures that affect either of these mechanisms could potentially result in EP.
This study is the first to look at whether the risk of EP is higher for women who use SSRIs, a common type of antidepressant that can affect ciliary beating in the fallopian tube, or benzodiazepines, a common type of anti-anxiety drug that can affect muscle contractions in the fallopian tube. The rate of SSRI and benzodiazepine prescriptions are rising, but virtually nothing is known about the impact of these medications on early pregnancy outcomes such as EP. This study will use large administrative claims databases of over 2 million pregnancies and advanced methods to make considerable strides toward understanding, and potentially reducing the incidence of, EP.
The findings from this research are important contributions to the fields of perinatal epidemiology and pharmacoepidemiology. Since EPs never progress past the first trimester, they are largely neglected in both fields. Given the serious outcomes associated with EPs (complications and death), this topic deserves a lot more attention. The rate of EP is high in Canada, ranging from less than 1% of reported pregnancies in Prince Edward Island, to more than 3% of reported pregnancies in the Northwest Territories. The findings from this research can contribute towards guidelines for the prescription of SSRIs and benzodiazepines for women of reproductive age in Canada.
Competitiondate
201809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Wall-Wieler, Elizabeth
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~